Adhera Therapeutics, Inc.
ATRX
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -96.00% | 173.74% | -1,097.30% | 79.93% | 51.77% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -68.38% | 25.24% | 247.43% | 223.81% | 669.70% |
| Total Other Non-Cash Items | 485.97% | -11.27% | 79.22% | -143.91% | -114.98% |
| Change in Net Operating Assets | 48.31% | 16.00% | -2.27% | 323.66% | 4,682.11% |
| Cash from Operations | 95.62% | 33.33% | -43.52% | 48.31% | -165.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -84.75% | 150.00% | -59.84% | -100.00% |
| Total Debt Repaid | 108.40% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7,750.00% | 100.00% | -190.00% | 37.93% | 100.33% |
| Cash from Financing | 107.63% | -76.23% | 92.78% | -76.36% | -113.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.45% | -101.36% | 202.78% | -34.67% | -756.61% |
